Target intelligence / Profile preview

Ribosomal protein L30 pseudogene 16 (RPL30P16)

Target
RPL30P16
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L30 pseudogene 16 (RPL30P16) is a *processed pseudogene* derived from the parent gene encoding ribosomal protein L30, part of the 60S ribosomal subunit[6][4]. Pseudogenes such as RPL30P16 are genetic elements with sequence similarity to their parent protein-coding genes but are non-functional, typically due to accumulation of disabling mutations or insertion as DNA without necessary regulatory elements[6][4]. Unlike the functional ribosomal protein L30 gene, which encodes a protein involved in protein synthesis within the ribosome[3][5], this pseudogene is not transcribed into a protein and does not have a known physiological role or involvement in disease, drug interactions, or therapeutic applications[6][4][2]. The correct therapeutic target would be "Ribosomal protein L30" (RPL30), not its pseudogene RPL30P16[3][5]. **Key points:** - RPL30P16 is a non-functional pseudogene, not a therapeutic target[6][4]. - It does not belong to common molecular classes such as receptor, enzyme, or transporter. - The entry "RPL30 pseudogene 16" refers to a genetic element with no established biological or pathological function, no role in disease, and no drug targeting or biomarker utility[6][4]. - If your intent was to refer to a ribosomal protein with therapeutic or research relevance, you should specify "Ribosomal protein L30" (RPL30)[3][5].

Other names
RPL30P16

Beyond the preview

Go deeper on Ribosomal protein L30 pseudogene 16 (RPL30P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L30 pseudogene 16 (RPL30P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call